187 related articles for article (PubMed ID: 30021604)
1. Paired box 8 suppresses tumor angiogenesis and metastasis in gastric cancer through repression of FOXM1 via induction of microRNA-612.
Wang L; Bo X; Zheng Q; Ge W; Liu Y; Li B
J Exp Clin Cancer Res; 2018 Jul; 37(1):159. PubMed ID: 30021604
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-630 Suppresses Epithelial-to-Mesenchymal Transition by Regulating FoxM1 in Gastric Cancer Cells.
Feng J; Wang X; Zhu W; Chen S; Feng C
Biochemistry (Mosc); 2017 Jun; 82(6):707-714. PubMed ID: 28601080
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of miR-6868-5p/FOXM1 circuit contributes to colorectal cancer angiogenesis.
Wang Y; Wu M; Lei Z; Huang M; Li Z; Wang L; Cao Q; Han D; Chang Y; Chen Y; Liu X; Xue L; Mao X; Geng J; Chen Y; Dai T; Ren L; Wang Q; Yu H; Chen C; Chu X
J Exp Clin Cancer Res; 2018 Nov; 37(1):292. PubMed ID: 30486864
[TBL] [Abstract][Full Text] [Related]
4. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
[TBL] [Abstract][Full Text] [Related]
5. microRNA-216b inhibits cell proliferation and migration in human melanoma by targeting FOXM1 in vitro and in vivo.
Sun M; Wang X; Tu C; Wang S; Qu J; Xiao S
Cell Biol Int; 2017 Dec; 41(12):1272-1282. PubMed ID: 28225180
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-194 inhibits the epithelial-mesenchymal transition in gastric cancer cells by targeting FoxM1.
Li Z; Ying X; Chen H; Ye P; Shen Y; Pan W; Zhang L
Dig Dis Sci; 2014 Sep; 59(9):2145-52. PubMed ID: 24748184
[TBL] [Abstract][Full Text] [Related]
7. miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer.
Sun Y; Yu X; Bai Q
Int J Clin Exp Pathol; 2015; 8(10):12775-83. PubMed ID: 26722467
[TBL] [Abstract][Full Text] [Related]
8. Role of FoxM1 in the Progression and Epithelial to Mesenchymal Transition of Gastrointestinal Cancer.
Zhang J; Niu Y; Huang C
Recent Pat Anticancer Drug Discov; 2017; 12(3):247-259. PubMed ID: 28440206
[TBL] [Abstract][Full Text] [Related]
9. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
10. FoxM1 is overexpressed in Helicobacter pylori-induced gastric carcinogenesis and is negatively regulated by miR-370.
Feng Y; Wang L; Zeng J; Shen L; Liang X; Yu H; Liu S; Liu Z; Sun Y; Li W; Chen C; Jia J
Mol Cancer Res; 2013 Aug; 11(8):834-44. PubMed ID: 23576572
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of FoxM1 leads to the inhibition of the epithelial-mesenchymal transition in gastric cancer cells.
Miao L; Xiong X; Lin Y; Cheng Y; Lu J; Zhang J; Cheng N
Cancer Genet; 2014 Mar; 207(3):75-82. PubMed ID: 24726291
[TBL] [Abstract][Full Text] [Related]
12. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
13. miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells.
Li J; Wang Y; Luo J; Fu Z; Ying J; Yu Y; Yu W
FEBS Lett; 2012 Oct; 586(20):3761-5. PubMed ID: 23010597
[TBL] [Abstract][Full Text] [Related]
14. MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer.
Zhang P; Tang WM; Zhang H; Li YQ; Peng Y; Wang J; Liu GN; Huang XT; Zhao JJ; Li G; Li AM; Bai Y; Chen Y; Ren YX; Li GX; Wang YD; Liu SD; Wang JD
Br J Cancer; 2017 Aug; 117(4):525-534. PubMed ID: 28632723
[TBL] [Abstract][Full Text] [Related]
15. Basic Transcription Factor 3 Is Required for Proliferation and Epithelial-Mesenchymal Transition via Regulation of FOXM1 and JAK2/STAT3 Signaling in Gastric Cancer.
Zhang DZ; Chen BH; Zhang LF; Cheng MK; Fang XJ; Wu XJ
Oncol Res; 2017 Nov; 25(9):1453-1462. PubMed ID: 28276310
[TBL] [Abstract][Full Text] [Related]
16. MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis.
Wang Y; Zeng J; Pan J; Geng X; Li L; Wu J; Song P; Wang Y; Liu J; Wang L
Oncotarget; 2016 May; 7(20):29275-86. PubMed ID: 27086911
[TBL] [Abstract][Full Text] [Related]
17. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer.
Yang C; Chen H; Tan G; Gao W; Cheng L; Jiang X; Yu L; Tan Y
Cancer Lett; 2013 Oct; 340(1):104-12. PubMed ID: 23856032
[TBL] [Abstract][Full Text] [Related]
18. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA CCAL/miR-149/FOXM1 axis promotes metastasis in gastric cancer.
Luo X; Wang GH; Bian ZL; Li XW; Zhu BY; Jin CJ; Ju SQ
Cell Death Dis; 2018 Sep; 9(10):993. PubMed ID: 30250169
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
